University of Chicago Section of Hematology/Oncology Lymphoma Program — Chicago, Illinois

University of Chicago Section of Hematology/Oncology Lymphoma Program is a clinical research site located in Chicago, Illinois, United States 60637-1470.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Chicago Section of Hematology/Oncology Lymphoma Program has participated in 1 clinical trials.

Therapeutic areas: Disease, Hodgkin.

Sponsors: Seagen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Section of Hematology/Oncology Lymphoma Program?

University of Chicago Section of Hematology/Oncology Lymphoma Program has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Section of Hematology/Oncology Lymphoma Program conducted?

University of Chicago Section of Hematology/Oncology Lymphoma Program has 1 clinical trials on record. Their work covers Disease, Hodgkin.

Is University of Chicago Section of Hematology/Oncology Lymphoma Program accredited by Crixeo Clinical Trials?

University of Chicago Section of Hematology/Oncology Lymphoma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago Section of Hematology/Oncology Lymphoma Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.